Clinical Trial Update: HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating HPV-specific immune lymphocytes (HPV-CTLs) for human papillomavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Human Papillomavirus-related Diseases

Drugs mentioned

• HPV-CTLs

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Human Papilloma Virus | Phase 1, Phase 2 | Status: UNKNOWN